Header Logo

Connection

Didem Saygin to Humans

Back to Details
This is a "connection" page, showing publications Didem Saygin has written about Humans.
Didem Saygin
Connection Strength
0.820
Humans
  1. Current myositis clinical trials and tribulations. Ann Rheum Dis. 2024 Jun 12; 83(7):826-829.
    View in: PubMed
    Score: 0.050
  2. Performance of the 2017 EULAR/ACR Classification Criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups: a scoping review. Clin Exp Rheumatol. 2024 Feb; 42(2):403-412.
    View in: PubMed
    Score: 0.049
  3. Serum cytokine profiles of adults with idiopathic inflammatory myopathies. Clin Exp Rheumatol. 2024 Feb; 42(2):229-236.
    View in: PubMed
    Score: 0.049
  4. Responsiveness and meaningful thresholds of PROMIS pain interference, fatigue, and physical function forms in adults with idiopathic inflammatory myopathies: Report from the OMERACT Myositis Working Group. Semin Arthritis Rheum. 2024 Feb; 64:152339.
    View in: PubMed
    Score: 0.048
  5. Performance of the 2016 ACR-EULAR Myositis Response Criteria in adult dermatomyositis/polymyositis therapeutic trials and consensus profiles. Rheumatology (Oxford). 2023 Nov 02; 62(11):3672-3679.
    View in: PubMed
    Score: 0.048
  6. Consumer-based activity trackers in evaluation of physical activity in myositis patients. Rheumatology (Oxford). 2022 Jul 06; 61(7):2951-2958.
    View in: PubMed
    Score: 0.044
  7. Immune Checkpoint Inhibitor-Associated Myositis: A Distinct Form of Inflammatory Myopathy. J Clin Rheumatol. 2022 Oct 01; 28(7):367-373.
    View in: PubMed
    Score: 0.044
  8. Glucocorticoids in Myositis: Initiation, Tapering, and Discontinuation. Curr Rheumatol Rep. 2022 Mar; 24(3):47-53.
    View in: PubMed
    Score: 0.043
  9. Assessment of Physical Activity and Muscle Function in Adult Inflammatory Myopathies. Curr Rheumatol Rep. 2022 Mar; 24(3):54-63.
    View in: PubMed
    Score: 0.043
  10. Hand-held dynamometry for assessment of muscle strength in patients with inflammatory myopathies. Rheumatology (Oxford). 2021 May 14; 60(5):2146-2156.
    View in: PubMed
    Score: 0.041
  11. Utility of patient-reported outcomes measurement information system (PROMIS) physical function form in inflammatory myopathy. Semin Arthritis Rheum. 2021 Jun; 51(3):539-546.
    View in: PubMed
    Score: 0.040
  12. Follow-up results of myositis patients treated with H. P. Acthar gel. Rheumatology (Oxford). 2020 Oct 01; 59(10):2976-2981.
    View in: PubMed
    Score: 0.039
  13. Differentiation between neurosarcoidosis and primary central nervous system vasculitis based on demographic, cerebrospinal and imaging features. Clin Exp Rheumatol. 2020; 38 Suppl 124(2):135-138.
    View in: PubMed
    Score: 0.037
  14. Tattoo reaction as a presenting manifestation of systemic sarcoidosis. Rheumatology (Oxford). 2019 May 01; 58(5):927.
    View in: PubMed
    Score: 0.035
  15. Microvascular involvement in systemic sclerosis and systemic lupus erythematosus. Microcirculation. 2019 Apr; 26(3):e12440.
    View in: PubMed
    Score: 0.035
  16. Relative quantification of beta-adrenergic receptor in peripheral blood cells using flow cytometry. Cytometry A. 2018 May; 93(5):563-570.
    View in: PubMed
    Score: 0.033
  17. Collaborative research in myositis-related disorders: MIHRA, a global shared community model. Clin Exp Rheumatol. 2024 Feb; 42(2):207-212.
    View in: PubMed
    Score: 0.012
  18. Evolving and evaluating the OMERACT fellows program: insights and implications from OMERACT 2023 fellows. Semin Arthritis Rheum. 2024 Apr; 65:152391.
    View in: PubMed
    Score: 0.012
  19. Discordance between patient- and physician-reported disease activity in adult idiopathic inflammatory myopathy. Rheumatology (Oxford). 2023 Dec 01; 62(12):3957-3961.
    View in: PubMed
    Score: 0.012
  20. Performance of the 2016 ACR-EULAR myositis response criteria in juvenile dermatomyositis therapeutic trials and consensus profiles. Rheumatology (Oxford). 2023 Nov 02; 62(11):3680-3689.
    View in: PubMed
    Score: 0.012
  21. A single center pilot study: assessing resident needs and faculty perceptions to improve training in rheumatology. BMC Med Educ. 2023 May 19; 23(1):351.
    View in: PubMed
    Score: 0.012
  22. RheumMadness: Creating an Online Community of Inquiry in Rheumatology. Arthritis Care Res (Hoboken). 2023 Nov; 75(11):2248-2258.
    View in: PubMed
    Score: 0.012
  23. Supporting International Medical Graduates in Rheumatology: A Call to Action. Arthritis Rheumatol. 2023 Feb; 75(2):145-148.
    View in: PubMed
    Score: 0.011
  24. Reliability and validity of PROMIS physical function, pain interference, and fatigue as patient reported outcome measures in adult idiopathic inflammatory myopathies: International study from the OMERACT myositis working group. Semin Arthritis Rheum. 2023 Feb; 58:152111.
    View in: PubMed
    Score: 0.011
  25. Report of the American College of Rheumatology Fellows-in-Training Subcommittee: experiences of rheumatology fellows early in the COVID-19 pandemic. Arthritis Rheumatol. 2022 Aug; 74(8):1457-1458.
    View in: PubMed
    Score: 0.011
  26. Reliability, validity and responsiveness of physical activity monitors in patients with inflammatory myopathy. Rheumatology (Oxford). 2021 Dec 01; 60(12):5713-5723.
    View in: PubMed
    Score: 0.011
  27. Long term follow-up of Behçet's syndrome patients treated with cyclophosphamide. Rheumatology (Oxford). 2020 Sep 01; 59(9):2264-2271.
    View in: PubMed
    Score: 0.010
  28. Long-term outcomes of patients with primary angiitis of the central nervous system. Clin Exp Rheumatol. 2019; 37 Suppl 117(2):45-51.
    View in: PubMed
    Score: 0.009
  29. Impact of a Post-Discharge Integrated Disease Management Program on COPD Hospital Readmissions. Respir Care. 2017 Nov; 62(11):1396-1402.
    View in: PubMed
    Score: 0.008
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.